[PDF][PDF] Bratati Sahaa, b, Oliver Varetteb, c, William L. Stanforda, d, Jean-Simon Diallob, c and Robin J.
RJ Parks, B Saha, O Varette, WL Stanford… - … and validation of …, 2019 - ruor.uottawa.ca
Human adenovirus (HAdV) can cause severe disease and death in both
immunocompromised and immunocompetent patients. The current standards of treatment …
immunocompromised and immunocompetent patients. The current standards of treatment …
[PDF][PDF] Bratati Sahaa, b, Oliver Varetteb, c, William L. Stanforda, d, Jean-Simon Diallob, c and Robin J.
RJ Parks, B Saha, O Varette… - … and validation of …, 2019 - dam-oclc.bac-lac.gc.ca
Human adenovirus (HAdV) can cause severe disease and death in both
immunocompromised and immunocompetent patients. The current standards of treatment …
immunocompromised and immunocompetent patients. The current standards of treatment …
[PDF][PDF] Bratati Sahaa, b, Oliver Varetteb, c, William L. Stanforda, d, Jean-Simon Diallob, c and Robin J.
RJ Parks, B Saha, O Varette… - … and validation of …, 2019 - scholar.archive.org
Human adenovirus (HAdV) can cause severe disease and death in both
immunocompromised and immunocompetent patients. The current standards of treatment …
immunocompromised and immunocompetent patients. The current standards of treatment …
[PDF][PDF] Bratati Sahaa, b, Oliver Varetteb, c, William L. Stanforda, d, Jean-Simon Diallob, c and Robin J.
RJ Parks, B Saha, O Varette, WL Stanford… - … and validation of …, 2019 - ruor.uottawa.ca
Human adenovirus (HAdV) can cause severe disease and death in both
immunocompromised and immunocompetent patients. The current standards of treatment …
immunocompromised and immunocompetent patients. The current standards of treatment …